As expected, expression of HLA-DR and CD86, which are well known as markers of M1 macrophages, were up-regulated on CD14+ monocytes within PBMC co-cultured with tumor cells in the presence of cetuximab (p = 0.004). Here, CD86 is linked to neoplasm.